You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 16, October 24/31, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Hypertension
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cocoa Intake and Blood Pressure—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: Drs Tsikas and Rossi question the validity of the S-nitrosoglutathione assay and the clinical relevance of S-nitrosoglutathione for the blood pressure reduction described in our article. Our study reported only data from methods that have been validated according to established medical, analytical, or regulatory guidelines. To facilitate assessment of data quality for the methods used to measure main outcomes—including the S-nitrosoglutathione concentrations—essential validation parameters were presented. Requiring preceding publication of the complete validation process before allowing publication of clinical data would hamper clinically relevant "real-world" research without improving quality and clarity of the studies.

Regarding use of an internal standard, isotope-labeled standards are preferred for the liquid chromatography tandem mass spectrometry quantification of stable analytes. However, S-nitrosoglutathione undergoes transnitrosylation reactions. Thus, the addition of labeled S-nitrosoglutathione (such as S-[15N]nitrosoglutathione)1 to the plasma samples leads to a reequilibration of nitric oxide (NO) . . . [Full Text of this Article]

Dirk Taubert, MD, PhD
dirk.taubert@medizin.uni-koeln.de
Department of Pharmacology

Norma Jung, MD
Department of Internal Medicine

Renate Roesen, PhD
Department of Pharmacology
University Hospital of Cologne
Cologne, Germany



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Cocoa Intake and Blood Pressure
Dimitrios Tsikas and Ranieri Rossi
JAMA. 2007;298(16):1862-1863.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.